Oxidative Stress and Inflammation in SARS-CoV-2- and Chlamydia pneumoniae-Associated Cardiovascular Diseases

Throughout the years, a growing number of studies have provided evidence that oxidative stress and inflammation may be involved in the pathogenesis of infectious agent-related cardiovascular diseases. Amongst the numerous respiratory pathogens, severe acute respiratory syndrome coronavirus 2 (SARS-C...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicines 2021-06, Vol.9 (7), p.723
Main Authors: Filardo, Simone, Di Pietro, Marisa, Diaco, Fabiana, Romano, Silvio, Sessa, Rosa
Format: Article
Language:English
Subjects:
Antioxidants
Asymptomatic
Atherosclerosis
Cardiovascular diseases
Chlamydia
Chlamydia pneumoniae
Coronaviruses
COVID-19
Cytokines
Disease transmission
Endothelium
Enzymes
Infections
Inflammation
Lipid peroxidation
Oxidative stress
Pandemics
Pathogenesis
Pathogens
Pneumonia
Reactive oxygen species
Respiratory diseases
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Thrombosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Throughout the years, a growing number of studies have provided evidence that oxidative stress and inflammation may be involved in the pathogenesis of infectious agent-related cardiovascular diseases. Amongst the numerous respiratory pathogens, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus responsible for the global ongoing pandemic, and Chlamydia pneumoniae, a widely known intracellular obligate bacteria, seem to have an essential role in promoting reactive oxygen species and cytokine production. The present review highlights the common oxidative and inflammatory molecular pathways underlying the cardiovascular diseases associated with SARS-CoV-2 or C. pneumoniae infections. The main therapeutic and preventive approaches using natural antioxidant compounds will be also discussed.
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines9070723